G. L. Eiben

发表

Targeting Viral Antigens for the Treatment of Malignancies

M. Nishimura, Gretchen L. Eiben, W. M. Kast, 2004 .

CD4 + T CELL MATTERS IN TUMOR IMMUNITY

Gretchen L. Eiben, M. Markiewicz, G. L. Eiben, 2003, International reviews of immunology.

HPV protein/peptide vaccines: from animal models to clinical trials.

I. L. Le Poole, Gretchen L. Eiben, W. Kast, 2003, Frontiers in bioscience : a journal and virtual library.

Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.

Larry R. Smith, L. Smith, Gretchen L. Eiben, 2001, Cancer research.

Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine1

Larry R. Smith, P. Kloetzel, Markwin P. Velders, 2001, The Journal of Immunology.

Cervical cancer vaccines: Emerging concepts and developments

M. Rudolf, Gretchen L. Eiben, W. Kast, 2001, Journal of cellular physiology.

The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy.

Gretchen L. Eiben, W. Kast, G. L. Eiben, 2002, Advances in cancer research.

Cervical cancer vaccines: recent advances in HPV research.

M. Nishimura, I. L. Le Poole, Gretchen L. Eiben, 2003, Viral immunology.

Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice.

Larry R. Smith, J. K. Pullen, H. Schreiber, 2002, Cancer research.

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes.

Larry R. Smith, J. K. Pullen, V. Shahabi, 2004, Vaccine.